Tanshinone IIA Reverses Oxaliplatin Resistance In Human Colorectal Cancer Via Inhibition Of ERK/Akt Signaling Pathway

BACKGROUND: Oxaliplatin (OXA)-based chemotherapy is generally used to treat human cancers, whereas OXA resistance is a main obstacle for the treatment of colorectal cancer (CRC). Evidence has shown that tanshinone IIA (Tan IIA) could induce apoptosis in CRC cells. However, the role of combination of...

全面介紹

Na minha lista:
書目詳細資料
發表在:Onco Targets Ther
Main Authors: Zhang, Yonggang, Ge, Tingrui, Xiang, Ping, Zhou, Jingyi, Tang, Shumin, Mao, Haibing, Tang, Qiang
格式: Artigo
語言:Inglês
出版: Dove 2019
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6859961/
https://ncbi.nlm.nih.gov/pubmed/32009805
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S217914
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍